On the other hand, neutralization of IL-1 signaling using Kineret® (Anakinra; ILRa) in clinical trials resulted only in a marginal trend for increased survival [ 61 ], whereas IL-18 neutralization has not been evaluated in clinical studies so far [ 62 ].
← all excerpts
Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids.
1
—
—